George L. Daikos

18.0k total citations · 4 hit papers
136 papers, 6.8k citations indexed

About

George L. Daikos is a scholar working on Molecular Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, George L. Daikos has authored 136 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Medicine, 53 papers in Epidemiology and 36 papers in Pharmacology. Recurrent topics in George L. Daikos's work include Antibiotic Resistance in Bacteria (66 papers), Antibiotics Pharmacokinetics and Efficacy (36 papers) and Antibiotic Use and Resistance (33 papers). George L. Daikos is often cited by papers focused on Antibiotic Resistance in Bacteria (66 papers), Antibiotics Pharmacokinetics and Efficacy (36 papers) and Antibiotic Use and Resistance (33 papers). George L. Daikos collaborates with scholars based in Greece, United States and Italy. George L. Daikos's co-authors include L. S. Tzouvelekis, A Markogiannakis, Mina Psichοgiou, Panayotis T. Tassios, Evangelia‐Theophano Piperaki, Vivì Miriagou, George Gee Jackson, V. T. Lolans, Helen Giamarellou and Maria Souli and has published in prestigious journals such as PLoS ONE, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

George L. Daikos

131 papers receiving 6.6k citations

Hit Papers

Carbapenemases in Klebsie... 2012 2026 2016 2021 2012 2019 2014 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George L. Daikos Greece 40 4.5k 2.4k 2.1k 1.4k 1.2k 136 6.8k
Federico Pérez United States 43 4.9k 1.1× 1.9k 0.8× 1.5k 0.7× 1.3k 0.9× 1.7k 1.4× 133 6.2k
David van Duin United States 48 5.5k 1.2× 2.8k 1.2× 3.3k 1.6× 2.0k 1.4× 1.5k 1.2× 176 9.7k
Jason M. Pogue United States 42 3.8k 0.8× 2.9k 1.2× 1.9k 0.9× 1.6k 1.1× 709 0.6× 155 6.4k
Teresa Spanu Italy 43 3.5k 0.8× 1.4k 0.6× 2.3k 1.1× 1.4k 1.0× 965 0.8× 130 6.5k
Ryan K. Shields United States 49 4.7k 1.0× 3.3k 1.3× 3.1k 1.5× 1.6k 1.1× 921 0.8× 199 7.4k
John Quale United States 40 4.7k 1.0× 2.2k 0.9× 1.5k 0.7× 1.4k 1.0× 1.5k 1.2× 108 6.6k
Fé Tubau Spain 44 3.1k 0.7× 1.5k 0.6× 2.6k 1.2× 869 0.6× 688 0.6× 173 6.1k
Simone Ambretti Italy 34 2.8k 0.6× 1.4k 0.6× 1.6k 0.8× 946 0.7× 689 0.6× 146 4.3k
Stephen G. Jenkins United States 45 3.1k 0.7× 1.3k 0.5× 2.3k 1.1× 829 0.6× 1.2k 1.0× 152 6.3k
Juan Pablo Horcajada Spain 47 2.8k 0.6× 1.2k 0.5× 3.3k 1.6× 1.1k 0.8× 1.1k 1.0× 238 8.0k

Countries citing papers authored by George L. Daikos

Since Specialization
Citations

This map shows the geographic impact of George L. Daikos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George L. Daikos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George L. Daikos more than expected).

Fields of papers citing papers by George L. Daikos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George L. Daikos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George L. Daikos. The network helps show where George L. Daikos may publish in the future.

Co-authorship network of co-authors of George L. Daikos

This figure shows the co-authorship network connecting the top 25 collaborators of George L. Daikos. A scholar is included among the top collaborators of George L. Daikos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George L. Daikos. George L. Daikos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gkoufa, Aikaterini, Alexandra Gavala, Stamatis Karakonstantis, et al.. (2026). Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant Acinetobacter baumannii infections: results from the DESPAIR study. Antimicrobial Agents and Chemotherapy. 70(3). e0115425–e0115425. 1 indexed citations
2.
Grabein, Béatrice, Francis F. Arhin, George L. Daikos, et al.. (2024). Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?. Infectious Diseases and Therapy. 13(11). 2423–2447. 7 indexed citations
4.
Basoulis, Dimitrios, Nikos Pantazis, Dimitrios Paraskevis, et al.. (2023). HIV RNA/DNA Levels at Diagnosis Can Predict Immune Reconstitution: A Longitudinal Analysis. Microorganisms. 11(6). 1510–1510. 2 indexed citations
5.
6.
Briassouli, Efrossini, Marianna Tzanoudaki, Dimitris Goukos, et al.. (2023). Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model. Nutrients. 15(1). 252–252. 1 indexed citations
7.
Ilia, Stavroula, Marina Mantzourani, Efrossini Briassouli, et al.. (2021). Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis. Scientific Reports. 11(1). 1049–1049. 20 indexed citations
8.
Vafea, Maria Tsikala, Dimitrios Basoulis, Ioanna D. Pavlopoulou, et al.. (2020). Bloodstream infections by gram‐negative bacteria in kidney transplant patients: Incidence, risk factors, and outcome. Transplant Infectious Disease. 22(6). e13442–e13442. 4 indexed citations
9.
Karapanou, Αmalia, et al.. (2020). Failure of central venous catheter insertion and care bundles in a high central line–associated bloodstream infection rate, high bed occupancy hospital. American Journal of Infection Control. 48(7). 770–776. 11 indexed citations
10.
Tsuji, Brian T., Jason M. Pogue, Alexandre Prehn Zavascki, et al.. (2019). International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(1). 10–39. 637 indexed citations breakdown →
11.
Tansarli, Giannoula S., Joseph Papaparaskevas, Michael Samarkos, et al.. (2018). Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis. International Journal of Antimicrobial Agents. 52(3). 397–403. 23 indexed citations
12.
Maltezou, Helena C., Maria Theodoridou, & George L. Daikos. (2017). Antimicrobial resistance and the current refugee crisis. Journal of Global Antimicrobial Resistance. 10. 75–79. 33 indexed citations
13.
Gutiérrez‐Gutiérrez, Belén, Jesús Sojo-Dorado, José María Bravo-Ferrer, et al.. (2017). EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study. BMJ Open. 7(4). e015365–e015365. 17 indexed citations
14.
Michos, Athanasios, et al.. (2016). Molecular analysis ofStreptococcus pyogenesmacrolide resistance of paediatric isolates during a 7 year period (2007–13). Journal of Antimicrobial Chemotherapy. 71(8). 2113–2117. 17 indexed citations
15.
Bamias, Giorgos, Ioanna Delladetsima, Spyros I. Siakavellas, et al.. (2016). Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease. Canadian Journal of Gastroenterology and Hepatology. 2016. 1–8. 6 indexed citations
16.
Daikos, George L., L. S. Tzouvelekis, Ioannis Anyfantis, et al.. (2014). Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems. Antimicrobial Agents and Chemotherapy. 58(4). 2322–2328. 463 indexed citations breakdown →
17.
Vasilakopoulou, Alexandra, Mina Psichοgiou, L. S. Tzouvelekis, et al.. (2009). Prevalence and Characterization of Class 1 Integrons in Escherichia coli of Poultry and Human Origin. Foodborne Pathogens and Disease. 6(10). 1211–1218. 21 indexed citations
18.
Kosmidis, Chris, Mina Psichοgiou, Panayotis T. Tassios, et al.. (2009). Prospective study of Klebsiella pneumoniae bacteremia:Risk factors and clinical significance of type VIM-1 metallo-beta-lactamases. Research Explorer (The University of Manchester). 2 indexed citations
19.
Petropoulou, Dimitra, et al.. (2006). Evaluation of Imipenem/Imipenem+EDTA Disk Method for Detection of Metallo- β -Lactamase-producing Klebsiella pneumoniae Isolated from Blood Cultures. Microbial Drug Resistance. 12(1). 39–43. 17 indexed citations
20.
Pavlopoulou, Ioanna D., George L. Daikos, Evangelia Petridou, et al.. (2004). Carriage of Neisseria meningitidis by Greek children: risk factors and strain characteristics. Clinical Microbiology and Infection. 10(2). 137–142. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026